Hematology | Clinical

Next Generation Treatments for Blood Cancers: Improved Outcomes in the Forecast

May 09, 2022

As these new techniques evolve and we adjust conditioning regimens, induction timing and dosing levels, as well as introducing different drug combinations, we are very hopeful that we will continue to see improved outcomes for hematologic malignancies, says Guenther Koehne, MD, PhD.